The scientist’s investigation covers issues in Immunology, Transplantation, Immune system, IL-2 receptor and Antigen. Much of her study explores Immunology relationship to In vivo. Her Transplantation study combines topics from a wide range of disciplines, such as Cytotoxic T cell, Immunosuppression, CD8 and Stem cell.
The study incorporates disciplines such as Vector, Nervous system and Cell biology in addition to Immune system. Her IL-2 receptor research includes elements of Molecular biology and Adoptive cell transfer. Her Antigen course of study focuses on Antigen presentation and Innate immune system.
Her primary scientific interests are in Immunology, Transplantation, Immune system, Antigen and Immunosuppression. As a part of the same scientific family, Kathryn J. Wood mostly works in the field of Immunology, focusing on In vivo and, on occasion, In vitro. Her research investigates the connection between Transplantation and topics such as Monoclonal antibody that intersect with problems in Ratón.
Her T cell study in the realm of Immune system connects with subjects such as Population. Her study brings together the fields of Intensive care medicine and Immunosuppression. The various areas that she examines in her IL-2 receptor study include Adoptive cell transfer and Cancer research.
Kathryn J. Wood focuses on Immunology, Transplantation, Immune system, Immunosuppression and Cell therapy. Antibody, T cell, Antigen, CD28 and IL-2 receptor are among the areas of Immunology where Kathryn J. Wood concentrates her study. Kathryn J. Wood studies Organ transplantation which is a part of Transplantation.
Her study looks at the relationship between Immune system and fields such as Cell biology, as well as how they intersect with chemical problems. Her Immunosuppression research is multidisciplinary, incorporating elements of Cancer, Tacrolimus, Oncology and Kidney transplantation. Her Cell therapy research includes themes of Adoptive cell transfer and Immune tolerance.
Her scientific interests lie mostly in Transplantation, Immunology, Immune system, Immunosuppression and Cell therapy. Her Transplantation study integrates concerns from other disciplines, such as T cell, Cancer research and Clinical trial. She has researched Immunology in several fields, including Cellular differentiation and Calcineurin.
Her work carried out in the field of Immune system brings together such families of science as Stem cell and Cell biology. Kathryn J. Wood studied Immunosuppression and Adverse effect that intersect with Clinical endpoint, Basiliximab, Maintenance therapy and Desensitization. The concepts of her Cell therapy study are interwoven with issues in Hematopoietic stem cell and Analytical chemistry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Regulatory T cells in transplantation tolerance.
Kathryn J. Wood;Shimon Sakaguchi.
Nature Reviews Immunology (2003)
CD25+CD4+ Regulatory T Cells Prevent Graft Rejection: CTLA-4- and IL-10-Dependent Immunoregulation of Alloresponses
Cherry I. Kingsley;Mahzuz Karim;Andrew R. Bushell;Kathryn J. Wood.
Journal of Immunology (2002)
IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo
Masaki Hara;Cherry I. Kingsley;Masanori Niimi;Simon Read.
Journal of Immunology (2001)
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans
Pervinder Sagoo;Esperanza Perucha;Birgit Sawitzki;Stefan Tomiuk.
Journal of Clinical Investigation (2010)
Indirect presentation of MHC antigens in transplantation
Daniel A. Shoskes;Kathryn J. Wood.
Immunology Today (1994)
Regulatory immune cells in transplantation
Kathryn J. Wood;Andrew Bushell;Joanna Hester.
Nature Reviews Immunology (2012)
IFN-γ production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo
Birgit Sawitzki;Birgit Sawitzki;Cherry I. Kingsley;Vanessa Oliveira;Mahzuz Karim.
Journal of Experimental Medicine (2005)
Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway.
M J Dallman;O Shiho;T H Page;K J Wood.
Journal of Experimental Medicine (1991)
In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells
Satish N Nadig;Joanna Więckiewicz;Douglas C Wu;Gregor Warnecke.
Nature Medicine (2010)
Mechanisms of Rejection: Current Perspectives
Kathryn J. Wood;Ryoichi Goto.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: